Thus, while we described an inverse interaction effect between PNPLA3 genotypes HOMAIR and TG in predicting the higher risk of hepatic steatosis, the modest sample size could be the reason why we did not identified synergy with BMI37. The gene discussed is PNPLA3; the disease is fatty liver disease.